Franklin Genomic Advancements Etf Price Patterns
| HELX Etf | USD 34.61 0.25 0.73% |
Momentum 47
Impartial
Oversold | Overbought |
Using Franklin Genomic hype-based prediction, you can estimate the value of Franklin Genomic Advancements from the perspective of Franklin Genomic response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Franklin Genomic using Franklin Genomic's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Franklin using crowd psychology based on the activity and movement of Franklin Genomic's stock price.
Franklin Genomic Implied Volatility | 0.34 |
Franklin Genomic's implied volatility exposes the market's sentiment of Franklin Genomic Advancements stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Franklin Genomic's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Franklin Genomic stock will not fluctuate a lot when Franklin Genomic's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Franklin Genomic to buy its etf at a price that has no basis in reality. In that case, they are not buying Franklin because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell etfs at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Franklin Genomic after-hype prediction price | USD 34.61 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as etf price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Franklin contract
Based on the Rule 16, the options market is currently suggesting that Franklin Genomic Advancements will have an average daily up or down price movement of about 0.0213% per day over the life of the 2026-05-15 option contract. With Franklin Genomic trading at USD 34.61, that is roughly USD 0.007355 . If you think that the market is fully incorporating Franklin Genomic's daily price movement you should consider acquiring Franklin Genomic Advancements options at the current volatility level of 0.34%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Franklin | Build AI portfolio with Franklin Etf |
Franklin Genomic After-Hype Price Density Analysis
As far as predicting the price of Franklin Genomic at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Franklin Genomic or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Etf prices, such as prices of Franklin Genomic, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Franklin Genomic Estimiated After-Hype Price Volatility
In the context of predicting Franklin Genomic's etf value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Franklin Genomic's historical news coverage. Franklin Genomic's after-hype downside and upside margins for the prediction period are 33.35 and 35.87, respectively. We have considered Franklin Genomic's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Franklin Genomic is very steady at this time. Analysis and calculation of next after-hype price of Franklin Genomic Adv is based on 3 months time horizon.
Franklin Genomic Etf Price Outlook Analysis
Have you ever been surprised when a price of a ETF such as Franklin Genomic is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Franklin Genomic backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Etf price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Franklin Genomic, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 1.26 | 0.00 | 0.00 | 3 Events / Month | 2 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
34.61 | 34.61 | 0.00 |
|
Franklin Genomic Hype Timeline
Franklin Genomic Adv is currently traded for 34.61. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Franklin is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Franklin Genomic is about 7411.76%, with the expected price after the next announcement by competition of 34.61. The company had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 3 days. Check out Franklin Genomic Basic Forecasting Models to cross-verify your projections.Franklin Genomic Related Hype Analysis
Having access to credible news sources related to Franklin Genomic's direct competition is more important than ever and may enhance your ability to predict Franklin Genomic's future price movements. Getting to know how Franklin Genomic's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Franklin Genomic may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MEDX | Horizon Kinetics Medical | (0.07) | 1 per month | 0.79 | 0.08 | 2.52 | (1.62) | 4.72 | |
| UCC | ProShares Ultra Consumer | (0.51) | 2 per month | 0.00 | (0.08) | 3.36 | (3.43) | 9.55 | |
| QRMI | Global X NASDAQ | (0.03) | 3 per month | 0.40 | (0.17) | 0.50 | (0.62) | 1.96 | |
| RHRX | Starboard Investment Trust | (0.01) | 2 per month | 0.76 | 0.01 | 1.29 | (1.63) | 4.08 | |
| XTJL | Innovator Equity Accelerated | 0.01 | 3 per month | 0.36 | (0.10) | 0.59 | (0.81) | 2.16 | |
| RW | EA Series Trust | 0.14 | 2 per month | 0.00 | (0.13) | 1.64 | (1.73) | 3.73 | |
| BYRE | Principal Exchange Traded Funds | 0.26 | 1 per month | 0.51 | 0.04 | 1.30 | (0.92) | 2.36 | |
| DGIN | VanEck ETF Trust | 0.02 | 4 per month | 0.00 | (0.19) | 1.65 | (1.87) | 6.87 | |
| FMKT | Tidal ETF Trust | 0.00 | 0 per month | 0.00 | (0.08) | 1.79 | (1.89) | 5.24 | |
| BWTG | Brendan Wood TopGun | 0.02 | 2 per month | 0.82 | (0.04) | 1.17 | (1.24) | 3.49 |
Franklin Genomic Additional Predictive Modules
Most predictive techniques to examine Franklin price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Franklin using various technical indicators. When you analyze Franklin charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Franklin Genomic Predictive Indicators
The successful prediction of Franklin Genomic stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Franklin Genomic Advancements, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Franklin Genomic based on analysis of Franklin Genomic hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Franklin Genomic's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Franklin Genomic's related companies.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Franklin Genomic Adv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Franklin Genomic's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Franklin Genomic Advancements Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Franklin Genomic Advancements Etf:Check out Franklin Genomic Basic Forecasting Models to cross-verify your projections. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
The market value of Franklin Genomic Adv is measured differently than its book value, which is the value of Franklin that is recorded on the company's balance sheet. Investors also form their own opinion of Franklin Genomic's value that differs from its market value or its book value, called intrinsic value, which is Franklin Genomic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Franklin Genomic's market value can be influenced by many factors that don't directly affect Franklin Genomic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Franklin Genomic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Franklin Genomic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Franklin Genomic's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.